Faes Farma SA (FAE):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10010
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Faes Farma SA (Faes Farma) develops, manufactures and commercializes pharmaceutical products and raw materials. The company offers prescription drugs, generic drugs, food supplements, over-the-counter (OTC) medications, baby foods, skin-care treatment products. It exports raw-materials and finished pharmaceutical products to pharmaceutical companies worldwide. Faes Farma also owns Ingaso farm, the animal nutrition and healthcare company. The company operates R&D center in Bilbao, Spain; a laboratory in Lisbon and production plants, subsidiaries and commercial offices in international markets. The company markets its products in Latin America, Asia, Europe, Africa and the Middle East. Faes Farma is headquartered in Madrid, Spain.

Faes Farma SA (FAE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Faes Farma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Faes Farma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Faes Farma SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Kyorin Pharma Enters into Development and Distribution Agreement with Faes Farma 10
Faes Farma to Form Joint Venture with Eddingpharm 11
Faes Farma Enters into Co- Marketing Agreement with Laboratorios Ordesa 12
Faes Farma Forms Joint Venture With Mexico’s Lab 13
Licensing Agreements 14
Tribute Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 14
Faes Farma Enters into Licensing Agreement with Marathon Pharma 15
FAES Farma Enters into License Agreement with Menarini For Bilastina 16
Taiho Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 17
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 19
FAES Farma And Pfizer Expand Bilastine License Agreement To 21 New Markets In Latin America 20
Laboratorios SALVAT Enters Into Licensing Agreement With FAES Farma 21
Equity Offering 22
Faes Farma to Raise USD0.53 Million in Offering of Shares 22
Acquisition 23
Faes Farma Acquires Laboratorios Diafarm for USD78.7 Million 23
Faes Farma SA – Key Competitors 24
Faes Farma SA – Key Employees 25
Faes Farma SA – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Affiliate 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Faes Farma SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Faes Farma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Faes Farma SA, Deals By Therapy Area, 2012 to YTD 2018 8
Faes Farma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Kyorin Pharma Enters into Development and Distribution Agreement with Faes Farma 10
Faes Farma to Form Joint Venture with Eddingpharm 11
Faes Farma Enters into Co- Marketing Agreement with Laboratorios Ordesa 12
Faes Farma Forms Joint Venture With Mexico's Lab 13
Tribute Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 14
Faes Farma Enters into Licensing Agreement with Marathon Pharma 15
FAES Farma Enters into License Agreement with Menarini For Bilastina 16
Taiho Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 17
Faes Farma And Invida Enter Into Licensing Agreement For Bilastine 19
FAES Farma And Pfizer Expand Bilastine License Agreement To 21 New Markets In Latin America 20
Laboratorios SALVAT Enters Into Licensing Agreement With FAES Farma 21
Faes Farma to Raise USD0.53 Million in Offering of Shares 22
Faes Farma Acquires Laboratorios Diafarm for USD78.7 Million 23
Faes Farma SA, Key Competitors 24
Faes Farma SA, Key Employees 25
Faes Farma SA, Subsidiaries 26
Faes Farma SA, Affiliate 26

List of Figures
Faes Farma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Faes Farma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Faes Farma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Faes Farma SA (FAE):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Akebia Therapeutics Inc (AKBA):企業の財務・戦略的SWOT分析
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • Teleflex Inc (TFX):医療機器:M&Aディール及び事業提携情報
    Summary Teleflex Inc (Teleflex) designs, develops, manufactures, and distributes disposable medical devices for use in critical care and surgery. Its major products include circuits, masks and bags, endotracheal tubes, pain pumps, supraglottic airways, catheters, adaptor and connectors. The company’ …
  • Engie Brasil Energia SA (EGIE3):企業の財務・戦略的SWOT分析
    Engie Brasil Energia SA (EGIE3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • EP Petroecuador:企業の戦略的SWOT分析
    EP Petroecuador - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • JG Summit Holdings Inc:企業の戦略・SWOT・財務情報
    JG Summit Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary JG Summit Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Qatar General Electricity and Water Corporation:企業の戦略的SWOT分析
    Qatar General Electricity and Water Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Grupo Argos SA:企業の戦略・SWOT・財務分析
    Grupo Argos SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Argos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Maverick Natural Resources LLC:企業の戦略的SWOT分析
    Maverick Natural Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • China Power Clean Energy Development Co Ltd (735):企業の財務・戦略的SWOT分析
    China Power Clean Energy Development Co Ltd (735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Milliken & Co:企業の戦略的SWOT分析
    Milliken & Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Net One Systems Co Ltd (7518):企業の財務・戦略的SWOT分析
    Net One Systems Co Ltd (7518) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Endocyte Inc (ECYT):企業の財務・戦略的SWOT分析
    Summary Endocyte Inc (Endocyte) is a biopharmaceutical company that develops targeted therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline products include Lu-PSMA-617 and Ac-PSMA-617 for radiologand therapy, and FITC CAR-T. Endocyte's proprietary small molecule dr …
  • Ambu AS (AMBU B):企業の財務・戦略的SWOT分析
    Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • NanoRepro AG (NN6):製薬・医療:M&Aディール及び事業提携情報
    Summary NanoRepro AG (NanoRepro) is a manufacturer of fast-diagnostics and nutritional food supplements for home and clinical use. The company offers wide range of rapid diagnostic tests products in the areas of family planning, disease detection (preventive healthcare), food intolerances, allergies …
  • Impinj Inc (PI):企業の財務・戦略的SWOT分析
    Impinj Inc (PI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Adverum Biotechnologies Inc (ADVM):製薬・医療:M&Aディール及び事業提携情報
    Summary Adverum Biotechnologies Inc (Adverum), formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-rela …
  • Clariant Ltd.:企業の戦略・SWOT・財務情報
    Clariant Ltd. - Strategy, SWOT and Corporate Finance Report Summary Clariant Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Intas Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and markets pharmaceuticals and biotechnology products for the treatment of a wide range of diseases and disorders in various therapeutic segments. The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropo …
  • Schroders Plc:企業の戦略・SWOT・財務分析
    Schroders Plc - Strategy, SWOT and Corporate Finance Report Summary Schroders Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Lietuvos energijos gamyba AB (LNR1L):企業の財務・戦略的SWOT分析
    Lietuvos energijos gamyba AB (LNR1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆